Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis

Slide: 5 of 46

Treatment of JIA (1 of 2)

Understanding both the circumstances in which DMARDs should be used and which DMARD should be selected is challenging because of the heterogeneity of the disease. Treatment approaches are based on the severity of symptoms.

The goal of treatment is to reduce pain, swelling, and joint damage. Typically treatment includes nonsteroidal anti-inflammatory drugs and corticosteroids (usually as intra-articular injections but sometimes orally). This approach does not cure the disease but may significantly reduce symptoms.